Inovio Pharmaceuticals Inc. (NASDAQ: INO)
$10.83
-0.3000 ( -2.70% ) 49.6K
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Market Data
Open
$10.83
Previous close
$11.13
Volume
49.6K
Market cap
$280.54M
Day range
$10.74 - $11.32
52 week range
$3.89 - $14.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 01, 2024 |
8-k | 8K-related | 13 | May 28, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
4 | Insider transactions | 1 | May 16, 2024 |